Gang Niu

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Apoptosis imaging: beyond annexin V
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Nucl Med 51:1659-62. 2010
  2. ncbi Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institute of Health, 9 Memorial Drive, Bethesda, MD 20892, USA
    Curr Drug Targets 11:1000-17. 2010
  3. ncbi MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides
    Orit Jacobson
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Mol Imaging Biol 13:1224-33. 2011
  4. ncbi Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS
    Ying Ma
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, 31 Center Dr, Suite 1C14, Bethesda, MD 20892 2281, USA
    Amino Acids 43:1625-32. 2012
  5. ncbi Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice
    Lixin Lang
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, Radiology and Imaging Sciences, Clinical Center, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, Maryland 20892, United States
    Bioconjug Chem 22:2415-22. 2011
  6. ncbi Improvement of CXCR4 tracer specificity for PET imaging
    Orit Jacobson
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, Maryland, USA
    J Control Release 157:216-23. 2012
  7. ncbi Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model
    Ning Guo
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS ONE 7:e37506. 2012
  8. ncbi PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue
    Haokao Gao
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, United States
    Mol Pharm 8:1775-82. 2011
  9. ncbi 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma
    Dale O Kiesewetter
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Eur J Nucl Med Mol Imaging 39:463-73. 2012
  10. ncbi Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes
    Xinglu Huang
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA
    Biomaterials 33:4370-8. 2012

Collaborators

Detail Information

Publications38

  1. ncbi Apoptosis imaging: beyond annexin V
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Nucl Med 51:1659-62. 2010
    ..It is highly possible that quantitative imaging of apoptosis will greatly improve clinical decision making in apoptosis-related diseases...
  2. ncbi Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institute of Health, 9 Memorial Drive, Bethesda, MD 20892, USA
    Curr Drug Targets 11:1000-17. 2010
    ..This review summarizes the current status of tumor therapeutic agents targeting to VEGF and the applications of VEGF related molecular imaging...
  3. ncbi MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides
    Orit Jacobson
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Mol Imaging Biol 13:1224-33. 2011
    ..4 h), using the chelator desferrioxamine-p-SCN (Df) for imaging tumor integrin α(v)β(3)...
  4. ncbi Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS
    Ying Ma
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, 31 Center Dr, Suite 1C14, Bethesda, MD 20892 2281, USA
    Amino Acids 43:1625-32. 2012
    ..The labeled antagonists (FP-NBBN, FB-NBBN, G-NBBN and FP-G-NBBN) displayed lower internalization. The optimal imaging agent will depend on the interplay of ligand metabolism, cellular uptake, and internalization in vivo...
  5. ncbi Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice
    Lixin Lang
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, Radiology and Imaging Sciences, Clinical Center, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, Maryland 20892, United States
    Bioconjug Chem 22:2415-22. 2011
    ..Considering their ease of preparation and good imaging qualities, [(18)F]FAl-NOTA-PRGD2 and [(68)Ga]NOTA-PRGD2 are promising alternatives to [(18)F]FPPRGD2 for PET imaging of tumor α(v)β(3) integrin expression...
  6. ncbi Improvement of CXCR4 tracer specificity for PET imaging
    Orit Jacobson
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, Maryland, USA
    J Control Release 157:216-23. 2012
    ..The tracers reported here may allow the evaluation of CXCR4 expression in primary tumors and metastatic nodules, and enable better informed, more personalized treatment for patients with cancer...
  7. ncbi Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model
    Ning Guo
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS ONE 7:e37506. 2012
    ....
  8. ncbi PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue
    Haokao Gao
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, United States
    Mol Pharm 8:1775-82. 2011
    ..The favorable characteristics of (18)F-FBEM-EM3106B, such as high specific activity and high tumor uptake, and high tumor to nontarget uptake, demonstrate that it is a promising tracer for clinical insulinoma imaging...
  9. ncbi 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma
    Dale O Kiesewetter
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Eur J Nucl Med Mol Imaging 39:463-73. 2012
    ..The abundance of GLP-1R in pancreatic β-cells in insulinoma, a cancer of the pancreas, and the activity of GLP-1 in the cardiovascular system have made GLP-1R a target for molecular imaging...
  10. ncbi Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes
    Xinglu Huang
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA
    Biomaterials 33:4370-8. 2012
    ..These findings provide very helpful guidance for the design of robust multifunctional nanomaterials in SLNs' mapping and tumor metastasis diagnosis...
  11. ncbi Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI
    Fan Zhang
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Biochem Biophys Res Commun 425:886-91. 2012
    ..In this study, we combined the use of iron oxide (IO) particles and nonspecific extracellular gadolinium chelate (Gd) in order to further improve the sensitivity and specificity of lesion detection...
  12. ncbi Imaging tumor endothelial marker 8 using an 18F-labeled peptide
    Qimeng Quan
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 9 Memorial Drive, 9 1 W111, Bethesda, MD 20892, USA
    Eur J Nucl Med Mol Imaging 38:1806-15. 2011
    ..TEM8 antagonists and TEM8-targeted delivery of toxins have been developed as effective cancer therapeutics. The ability to image TEM8 expression would be of use in evaluating TEM8-targeted cancer therapy...
  13. ncbi Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery
    Xinglu Huang
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, United States
    Biomaterials 34:1772-80. 2013
    ..As a proof-of-concept, this MSC platform opens a new vision for multifunctional applications of cell products by combining the superiority of stem cells and nanoparticles for actively targeted delivery...
  14. ncbi Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions
    Lei Zhu
    National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Maryland 20892, United States
    Bioconjug Chem 22:1001-5. 2011
    ..This strategy can be easily tuned for a wide array of applications targeting various receptors and extracellular proteases in vivo...
  15. ncbi Rapid and simple one-step F-18 labeling of peptides
    Orit Jacobson
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, Maryland, USA
    Bioconjug Chem 22:422-8. 2011
    ..Successful introduction of 4-fluoro-3-trifluoromethylbenzamide into RGD peptides may be a general strategy applicable to other biologically active peptides and proteins...
  16. ncbi Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Theranostics 3:190-200. 2013
    ....
  17. ncbi Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain
    Orit Jacobson
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Nucl Med 52:600-7. 2011
    ..Blocking this receptor might prove useful for reducing pain and for cancer therapy. However, there is no method to quantify the levels of these receptors in vivo...
  18. ncbi Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
    Dale O Kiesewetter
    1 Laboratory of Molecular Imaging, National Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, MD 20892, USA
    Theranostics 2:999-1009. 2012
    ..18)F]AlF-NOTA-MAL-exendin-4 shows high tumor uptake and highly selective GLP-1 tissue uptake (INS-1 tumor, lung, pancreas), but still suffers from high kidney uptake...
  19. ncbi Molecular targeting of CEACAM6 using antibody probes of different sizes
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    J Control Release 161:18-24. 2012
    ....
  20. ncbi Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425
    Abesh Kumar Bhattacharjee
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA
    Nucl Med Biol 38:897-906. 2011
    ....
  21. ncbi Tumor hypoxia imaging
    Xilin Sun
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892 2281, USA
    Mol Imaging Biol 13:399-410. 2011
    ..Special emphasis was placed on noninvasive imaging hypoxia with emerging new agents and new imaging technologies to detect the molecular events that are relevant to tumor hypoxia...
  22. ncbi Phage display-derived peptides for osteosarcoma imaging
    Xilin Sun
    National Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, MD, USA
    Clin Cancer Res 16:4268-77. 2010
    ....
  23. ncbi N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery
    Gang Liu
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Small 7:2742-9. 2011
    ..In conclusion, Alkyl-PEI2k-IOs demonstrate highly efficient delivery of siRNA and an innocuous toxic profile, making it a potential carrier for gene therapy...
  24. ncbi Sticky nanoparticles: a platform for siRNA delivery by a bis(zinc(II) dipicolylamine)-functionalized, self-assembled nanoconjugate
    Gang Liu
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health, USA
    Angew Chem Int Ed Engl 51:445-9. 2012
    ....
  25. ncbi Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging
    Hui Wang
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Theranostics 2:607-17. 2012
    ..Further study of [(18)F] FBEM-scVEGF to evaluate angiogenesis in cancer and other disease types is warranted...
  26. ncbi New Methods for Labeling RGD Peptides with Bromine-76
    Lixin Lang
    1 Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, Maryland, 20892, USA
    Theranostics 1:341-53. 2011
    ..The energy barrier difference of the transition states of bromination between the dimethoxybenzoyl group and the tyrosine residue may account for the reaction selectivity when both groups are present in the same molecule...
  27. ncbi Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging
    Yunpeng Ye
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA
    Bioorg Med Chem Lett 21:1146-50. 2011
    ..Both 1 and 2 showed significant tumor localization in optical imaging of MDA-MB-435 tumor-bearing mice. The potential of such iRGD compounds in tumor-targeted imaging and drug delivery deserves further exploration...
  28. ncbi 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy
    Xilin Sun
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892 2281, USA
    J Nucl Med 52:140-6. 2011
    ..The aim of this study was to investigate whether the integrin-specific PET tracer 18F-FPPRGD2 (investigational new drug 104150) can be used to monitor early response of tumors to Abraxane therapy...
  29. ncbi A ketogenic diet increases brown adipose tissue mitochondrial proteins and UCP1 levels in mice
    Shireesh Srivastava
    Laboratory of Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD, USA
    IUBMB Life 65:58-66. 2013
    ..5-fold higher, suggesting increased sympathetic system activity. These results demonstrate that a KD can also increase BAT mitochondrial size and protein levels...
  30. ncbi Multimodality imaging of tumor response to doxil
    Fan Zhang
    1 Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Theranostics 1:302-9. 2011
    ....
  31. ncbi Preclinical lymphatic imaging
    Fan Zhang
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Mol Imaging Biol 13:599-612. 2011
    ....
  32. ncbi LC/MS evaluation of metabolism and membrane transport of bombesin peptides
    Dongyu Gu
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 31 Center Dr, Suite 1C14, Bethesda, MD, 20892 2281, USA
    Amino Acids 40:669-75. 2011
    ..The antagonist ligand is potentially more useful for receptor-targeted imaging due primarily to its higher metabolic stability...
  33. ncbi Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy
    Peng Huang
    Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China Institute of Micro Nano Science and Technology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Biomaterials 34:4643-54. 2013
    ....
  34. ncbi Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet
    Shireesh Srivastava
    Laboratory of Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland 20852, USA
    FASEB J 26:2351-62. 2012
    ..The quantitative insulin-sensitivity check index was 73% higher in the KE group. These results identify KE as a potential antiobesity supplement...
  35. ncbi Chimeric ferritin nanocages for multiple function loading and multimodal imaging
    Xin Lin
    Laboratory of Molecular Imaging and Nanomedicine LOMIN, National Institute of Biomedical Imaging and Bioengineering NIBIB, National Institutes of Health NIH, Bethesda, Maryland 20892, USA
    Nano Lett 11:814-9. 2011
    ..This, in combination with the generalizability of the function loading techniques, promises ferritin particles as a powerful nanoplatfom in the era of nanomedicine...
  36. ncbi Molecular imaging with activatable reporter systems
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, 20892, USA
    Theranostics 2:413-23. 2012
    ..The applications of several types of activatable reporters will also be summarized. We conclude that activatable reporter imaging can benefit both basic biomedical research and drug development...
  37. ncbi Size effect in molecular imaging of vascular endothelial growth factor
    Gang Niu
    Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA
    Chem Biol 18:819-20. 2011
    ..The small peptidic probes described by Fedorova et al. in this issue appear to be superior to antibodies in reflecting the dynamics of VEGF as they facilitate image quantification...
  38. ncbi Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma
    Gang Niu
    Imaging Sciences Training Program, Radiology and Imaging Sciences, Clinical Center and National Institute of Biomedical Imaging and Bioengineering, National Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, MD20892, USA
    Clin Cancer Res 16:2095-105. 2010
    ....